FRIDAY, Jan. 24, 2025 -- Incorporating multiparametric magnetic resonance imaging (mpMRI) for initial staging can reduce the time to correct treatment...

JNJ's regulatory filing seeks the FDA's approval for TAR-200, a drug-device combination for treating certain bladder cancer patients.

THURSDAY, Jan. 30, 2025 -- The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA)...

THURSDAY, Jan. 23, 2025 -- For patients diagnosed with cancer, high muscle strength and cardiorespiratory fitness (CRF) are associated with a reduced...

A recent study finds that sequential gemcitabine/docetaxel treatment offers better outcomes than additional BCG therapy for patients with...

The results of a VHIO-led study published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR), underscore...

A recent analysis has revealed a strong connection between physical strength, fitness, and a longer life for people with cancer. The study, published...

TUESDAY, Jan. 21, 2025 -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk...

TUESDAY, Jan. 21, 2025 -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk...

Engaging in regular physical activity before being diagnosed with cancer may reduce the risk of disease progression and death, according to a study...